Interferon Gamma ELISPOT Testing as a Risk-Stratifying Biomarker for Kidney Transplant Injury: Results From the CTOT-01 Multicenter Study
干扰素γ ELISPOT检测作为肾移植损伤风险分层生物标志物：来自CTOT-01多中心研究的结果
期刊:American Journal of Transplantation
影响因子:8.2
doi:10.1111/ajt.13401
Hricik, D E; Augustine, J; Nickerson, P; Formica, R N; Poggio, E D; Rush, D; Newell, K A; Goebel, J; Gibson, I W; Fairchild, R L; Spain, K; Iklé, D; Bridges, N D; Heeger, P S
